BCX — Bioceltix SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN263.05m
- PLN256.15m
Annual cashflow statement for Bioceltix SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.6 | -2.35 | -4.4 | -8.92 | -13.7 |
| Depreciation | |||||
| Non-Cash Items | 0.002 | 0.05 | -0.065 | -0.055 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.122 | 0.604 | 0.067 | 0.656 | -1.49 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.67 | -1.47 | -4.02 | -7.87 | -14.7 |
| Capital Expenditures | -0.18 | -0.014 | -0.006 | -0.352 | -0.458 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | 0.14 | 0 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.18 | -0.014 | 0.134 | -0.352 | -0.458 |
| Financing Cash Flow Items | -0.002 | -0.04 | -0.022 | -0.032 | -0.154 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.38 | 3.59 | 6.74 | 6.29 | 20.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.47 | 2.1 | 2.85 | -1.93 | 5.19 |